abstract |
The present disclosure relates to a type A botulinum toxin complex, and a formulation and used thereof. The botulinum toxin type A complex includes HA70, HA17, HA33, NTNH and BoNT / A1. The molecular weight of the botulinum toxin complex is 740 ~ 790 kDa. Comparing to the prior botulinum toxin complex, the botulinum toxin complex of the present disclosure has a smaller molecular weight, higher safety, and a considerable therapeutic effect. |